Clinical Trials Logo

Urinary Bladder Neoplasms clinical trials

View clinical trials related to Urinary Bladder Neoplasms.

Filter by:

NCT ID: NCT03274284 Not yet recruiting - Bladder Cancer Clinical Trials

Chemoradiotherapy for Recurrent T1G3 Bladder Cancer

Start date: October 2017
Phase: Phase 4
Study type: Interventional

To evaluate the short term results of chemoradiation in case of T1G3 BC after BCG failure.

NCT ID: NCT03254888 Not yet recruiting - Bladder Cancer Clinical Trials

Autophagy Bladder Cancer

Start date: December 1, 2020
Phase:
Study type: Observational

• Bladder cancer is the most common malignancy of the urinary tract. It represents the 7th most commonly diagnosed cancer in male population worldwide and drops to the 11th when both genders are considered . According to the American cancer society's estimates of bladder cancer in 2017, the number of the new cases of bladder cancer is 79,030, and the mortality figures reached 16,870 .

NCT ID: NCT03221062 Not yet recruiting - Clinical trials for Non-muscle Invasive Bladder Cancer

"En Bloc" Resection of NMIBC: a Prospective, Single Centre,Randomized Study

Start date: August 1, 2017
Phase: Phase 4
Study type: Interventional

The traditional method of choice for intravesical resection of bladder tumors is conventional transurethral resection of bladder tumor (cTURBT). However, there has long been an ambition to overcome its biggest limitation, tumor fragmentation. Possible consequences include cell seeding and poor specimen quality, including missing detrusor muscle, thermal tissue damage, and tissue fragmentation. En bloc resection of bladder tumor (ERBT) represents an alternative technique for resection of bladder tumors. There is no doubt that ERBT has huge potential. ERBT provides specimens of high quality that are easy for pathologists to read. In theory, this may sustainably change the view on secondary resection, lead to faster decisions on subsequent treatments, and influence patient prognosis. Thus, there is an urgent need to compare ERBT with cTURBT in a thoroughly planned trial.

NCT ID: NCT03108261 Not yet recruiting - Clinical trials for Metastatic Urothelial Carcinoma

Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations

Start date: May 1, 2017
Phase: Phase 2
Study type: Interventional

This pilot phase II trial studies how well sapanisertib works in treating patients with bladder cancer that has spread from where it started to nearby tissue or lymph nodes (locally advanced) or other places in the body (metastatic) with tuberous sclerosis (TSC)1 and/or TSC2 mutations (changes in deoxyribonucleic acid [DNA]).Sapanisertib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

NCT ID: NCT02951078 Not yet recruiting - Bladder Cancer Clinical Trials

A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer

Start date: January 2017
Phase: Phase 3
Study type: Interventional

This study is to verify the short-term efficacy and long-term prognosis of thulium laser resection compared with conventional transurethral resection of non-muscular invasive bladder cancer. Half of participants will receive thulium laser resection of bladder cancer, while the other half will receive electrical transurethral resection of bladder cancer.

NCT ID: NCT02841904 Not yet recruiting - Bladder Cancer Clinical Trials

The Accuracy of Optic Biopsies Versus Conventional Biopsies for the Diagnosis of Superficial Bladder Neoplasia

Start date: June 2018
Phase: N/A
Study type: Interventional

This study evaluates the accuracy of Confocal Laser Endomicroscopy (CLE) in the diagnostic of non-invasive flat and exophytic bladder neoplasia. CLE results are compared to histopathology results.

NCT ID: NCT02760953 Not yet recruiting - Clinical trials for Urinary Bladder Neoplasms

TURBt With Adjuvant Cryoablation to Treat Bladder Cancer

Start date: October 19, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of applying cryoablation as an adjuvant therapy with TUR to treat bladder tumor.

NCT ID: NCT02600481 Not yet recruiting - Prostatic Neoplasms Clinical Trials

Impacts of Different Pressure Pneumoperitoneum on Myocardial and Pulmonary Injuries After Robot-assisted Surgery

Start date: January 2016
Phase: N/A
Study type: Interventional

This study is aimed to determine whether low- and standard-pressure pneumoperitoneum have different impacts on troponin T(TnT) level as well as pulmonary complications after prolonged robot-assisted surgeries in the Trendelenburg position.

NCT ID: NCT02534623 Not yet recruiting - Clinical trials for Urinary Bladder Neoplasms

Postoperative Quality of Recovery After Transurethral Resection of the Bladder

Start date: September 2015
Phase: N/A
Study type: Interventional

Transurethral resection of the bladder (TURB) is often performed as an outpatient procedure so high-quality postoperative recovery is particularly important. The aim of this study is to compare postoperative quality of recovery after spinal anesthesia (SA) and general anesthesia (GA) for transurethral resection of the bladder.

NCT ID: NCT02496442 Not yet recruiting - Clinical trials for Prostatic Hyperplasia

Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan

Start date: July 2015
Phase: N/A
Study type: Interventional

A. Synopsis 1. This protocol comes to direct the experiment to be performed on the Aqueduct Automatic Continuous Irrigation system. 2. The Aquaduct System is aimed at reducing risks to the patient by decreasing the irrigation fluid pressure he may be exposed to, reducing the procedure time and therefore the anesthesia time, reducing the manual handling of the sterile bags and the risk of contamination and more. 3. In general since there is no new procedure suggested and the equipment does not actually come into contact with the human body in any direct way, there is no need to have a clinical study for the regulation purpose. The reason for performing this experiment is to demonstrate the new system and to find out the best way to operate it in order to improve the process and reduce risks. 4. This information will serve the development of most suitable automation solution for achieving the long desired continuous irrigation. 5. The experiment will be performed in the OR in MIS procedures, and will replace the standard gravitational manual method of performing the irrigation. The surgeons and the medical staff of the OR will be directed with the set up and operation of the system prior to using it. The experiment will be accompanied at all times with a knowledgeable representative of the research originator. 6. A maximum of 30 procedures will be analyzed during a period of approximately one month. The surgeons and the medical staff will report their impression of using the system during the procedures and will recommend the best settings achieved. This information will be used to improve the system performance and design.